{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:49Z","timestamp":1791839869859,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98267","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:54:23Z","timestamp":1764629663000},"source":"Crossref","is-referenced-by-count":1,"title":["Navigating the Misdiagnosis of Pityriasis Rubra Pilaris and Successful Treatment With Guselkumab: A Case Report of Dual Biologic Therapy"],"prefix":"10.7759","author":[{"given":"Danika","family":"Bongfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Martinez-Cabriales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231223159","article-title":"Updates on pityriasis rubra pilaris: a scoping review","volume":"28","author":"Zhou T","year":"2024","unstructured":"Zhou T, Al Muqrin A, Abu-Hilal M. Updates on pityriasis rubra pilaris: a scoping review. J Cutan Med Surg. 2024, 28:158-66. 10.1177\/12034754231223159","journal-title":"J Cutan Med Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38657","article-title":"Misdiagnosed pityriasis rubra pilaris successfully managed with isotretinoin: a case series","volume":"15","author":"Al Khalifa N","year":"2023","unstructured":"Al Khalifa N, Alsabbagh M, Raees M, Aljufairi E. Misdiagnosed pityriasis rubra pilaris successfully managed with isotretinoin: a case series. Cureus. 2023, 15:e38657. 10.7759\/cureus.38657","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.107","article-title":"The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: a mixed methods study","volume":"2","author":"Velasco RC","year":"2023","unstructured":"Velasco RC, Cutler B, McCue W, Greiling TM. The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: a mixed methods study. JEADV Clin Pract. 2023, 2:184-92. 10.1002\/jvc2.107","journal-title":"JEADV Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.057","article-title":"Biologic treatment options for pityriasis rubra pilaris: an evidence-based systematic review","volume":"89","author":"Sood S","year":"2023","unstructured":"Sood S, Akuffo-Addo E, Yeung J, Mufti A. Biologic treatment options for pityriasis rubra pilaris: an evidence-based systematic review. J Am Acad Dermatol. 2023, 89:1306-8. 10.1016\/j.jaad.2023.08.057","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.036","article-title":"Biologics for pityriasis rubra pilaris treatment: a review of the literature","volume":"79","author":"Napolitano M","year":"2018","unstructured":"Napolitano M, Abeni D, Didona B. Biologics for pityriasis rubra pilaris treatment: a review of the literature. J Am Acad Dermatol. 2018, 79:353-359.e11. 10.1016\/j.jaad.2018.03.036","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.0257","article-title":"Guselkumab for pityriasis rubra pilaris and dysregulation of IL-23\/IL-17 and NFkB signaling: a nonrandomized trial","volume":"160","author":"Velasco RC","year":"2024","unstructured":"Velasco RC, Shao C, Cutler B, et al.. Guselkumab for pityriasis rubra pilaris and dysregulation of IL-23\/IL-17 and NFkB signaling: a nonrandomized trial. JAMA Dermatol. 2024, 160:641-5. 10.1001\/jamadermatol.2024.0257","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241238735","article-title":"Biologics for treatment of pityriasis rubra pilaris: a literature review","volume":"28","author":"Chandy RJ","year":"2024","unstructured":"Chandy RJ, Chokshi A, Tan I, Feldman SR. Biologics for treatment of pityriasis rubra pilaris: a literature review. J Cutan Med Surg. 2024, 28:269-75. 10.1177\/12034754241238735","journal-title":"J Cutan Med Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14761","article-title":"Pityriasis rubra pilaris: algorithms for diagnosis and treatment","volume":"32","author":"Roenneberg S","year":"2018","unstructured":"Roenneberg S, Biedermann T. Pityriasis rubra pilaris: algorithms for diagnosis and treatment. J Eur Acad Dermatol Venereol. 2018, 32:889-98. 10.1111\/jdv.14761","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.2774","article-title":"Treatment of pityriasis rubra pilaris with guselkumab","volume":"155","author":"Pilz AC","year":"2019","unstructured":"Pilz AC, Seiringer P, Biedermann T, Eyerich K. Treatment of pityriasis rubra pilaris with guselkumab. JAMA Dermatol. 2019, 155:1424-6. 10.1001\/jamadermatol.2019.2774","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14403","article-title":"Successful treatment of pityriasis rubra pilaris with guselkumab: serum CCL20 as a potential marker for the disease activity","volume":"33","author":"Nagai H","year":"2020","unstructured":"Nagai H, Jimbo H, Matsuura S, Tatsuoka S, Shiraki E, Nishigori C. Successful treatment of pityriasis rubra pilaris with guselkumab: serum CCL20 as a potential marker for the disease activity. Dermatol Ther. 2020, 33:e14403. 10.1111\/dth.14403","journal-title":"Dermatol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13676","article-title":"Combination treatment with monoclonal antibodies: secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma","volume":"62","author":"Mahar PD","year":"2021","unstructured":"Mahar PD, Zubrinich CM, Manuelpillai N, Foley P. Combination treatment with monoclonal antibodies: secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma. Australas J Dermatol. 2021, 62:506-8. 10.1111\/ajd.13676","journal-title":"Australas J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001222","article-title":"Pityriasis rubra pilaris with extensive follicular acantholysis resembling pemphigus vulgaris: a case report","volume":"41","author":"Lilo MT","year":"2019","unstructured":"Lilo MT, Yan S, Chapman MS, Linos K. Pityriasis rubra pilaris with extensive follicular acantholysis resembling pemphigus vulgaris: a case report. Am J Dermatopathol. 2019, 41:37-9. 10.1097\/DAD.0000000000001222","journal-title":"Am J Dermatopathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0091","article-title":"Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris: a case series of 100 patients","volume":"152","author":"Ross NA","year":"2016","unstructured":"Ross NA, Chung HJ, Li Q, Andrews JP, Keller MS, Uitto J. Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris: a case series of 100 patients. JAMA Dermatol. 2016, 152:670-5. 10.1001\/jamadermatol.2016.0091","journal-title":"JAMA Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00836-x","article-title":"Pityriasis rubra pilaris: an updated review of clinical presentation, etiopathogenesis, and treatment options","volume":"25","author":"Joshi TP","year":"2024","unstructured":"Joshi TP, Duvic M. Pityriasis rubra pilaris: an updated review of clinical presentation, etiopathogenesis, and treatment options. Am J Clin Dermatol. 2024, 25:243-59. 10.1007\/s40257-023-00836-x","journal-title":"Am J Clin Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198608000-00001","article-title":"Histologic criteria for the diagnosis of pityriasis rubra pilaris","volume":"8","author":"Soeprono FF","year":"1986","unstructured":"Soeprono FF. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol. 1986, 8:277-83. 10.1097\/00000372-198608000-00001","journal-title":"Am J Dermatopathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/438051-navigating-the-misdiagnosis-of-pityriasis-rubra-pilaris-and-successful-treatment-with-guselkumab-a-case-report-of-dual-biologic-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:54:24Z","timestamp":1764629664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/438051-navigating-the-misdiagnosis-of-pityriasis-rubra-pilaris-and-successful-treatment-with-guselkumab-a-case-report-of-dual-biologic-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.98267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}